Radhika Tripuraneni
Chief Medical Officer; Director · 4 filings · Latest: Aug 14, 2026
Terns Pharmaceuticals, Inc.
Viridian Therapeutics, Inc.\DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VRDN | Radhika Tripuraneni | Chief Medical Officer | Aug 14, 2026 | Option Exercise | $13.21 | 40,000 | $528.4K | 40,000 |